Log in  First Connection?

MelanomaArchives

Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
Melanoma
 5 min.

 Published on 17/03/2025 |  Original article (Full-text)  | Tod Bianca et al. | Journal of Skin Cancer, 2025, 4779587

Acral melanoma (AM), defined here as melanoma arising on the palm, sole, or nail apparatus, is a unique subtype of malignant melanoma. It differs from other melanoma subtypes in terms of epidemiology, clinical and pathological features, prognosis, and molecular characteristics [1–3]. Our knowledge...

A case of subcutaneous metastatic malignant melanoma of the left medial ankle: a case report and review of literature
Melanoma
 3 min.

 Published on 10/03/2025 |  Original article (Full-text)  | Workman Lauren et al. | Journal of Medical Case Reports 2024; 18(1): 647

When a patient presents with malignant melanoma without evidence of an epidermal component, the differential diagnosis may include melanoma of unknown primary (MUP) which can present as palpable lymphadenopathy or as a solitary dermal lesion. As defined by Das Gupta, MUP involves presence of melanoma...

Evidence of 18F-FDG Utility in Rare Case of Metastatic Anal Melanoma With Prolonged Survival
Melanoma
 1 min.

 Published on 03/03/2025 |  Original article (Full-text)  | Ranes, Jennifer Marie Catherine MD et al. | Clinical Nuclear Medicine 2025; 50(3): 257-60

A 43-year-old woman presented with an anorectal mass at which time excision was performed, and biopsy revealed anorectal mucosal melanoma (AM), anal subtype. Postexcision, F-FDG PET/CT identified residual melanoma, confirmed on biopsy. Recurrence was monitored every 3 months using F-FDG, which identified...

Blue Nevus‐Like Metastatic Melanoma in a Patient With Primary Lentigo Maligna Melanoma
Melanoma
 2 min.

 Published on 24/02/2025 |  Original article (Full-text)  | Kristen Fernandez et al. | Journal of Cutaneous Pathology 2025; AOP: 10.1111/cup.14765

Metastatic melanoma carries a poor prognosis, with a 5‐year survival rate around 10%, and distant metastases having a less favorable prognosis than local spread or recurrence [1]. The skin is the most common site involved by metastatic melanoma, observed in approximately in 50%–60% of cases [2]....

Predicting BRAF Mutations in Cutaneous Melanoma Patients Using Neural Network Analysis
Melanoma
 4 min.

 Published on 17/02/2025 |  Original article (Full-text)  | Dudin Oleksandr et al. | Journal of Skin Cancer, 2024, 3690228

Management of patients with cutaneous melanoma (CM) depends on assessing molecular biomarkers that enable personalization of patient treatment. The genetic landscape of melanoma is complex and variable depending on histological subtype, location, and individual characteristics, which affects heterogeneous...